Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Prologis
PLD
|
$582M |
| 2 |
Air Products & Chemicals
APD
|
$473M |
| 3 |
Pfizer
PFE
|
$407M |
| 4 |
General Dynamics
GD
|
$253M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$252M |
Top Sells
| 1 |
Cadence Design Systems
CDNS
|
$734M |
| 2 |
Goldman Sachs
GS
|
$451M |
| 3 |
Northrop Grumman
NOC
|
$411M |
| 4 |
Edwards Lifesciences
EW
|
$389M |
| 5 |
Thermo Fisher Scientific
TMO
|
$389M |
Sector Composition
| 1 | Financials | 19.48% |
| 2 | Technology | 17.38% |
| 3 | Healthcare | 16.61% |
| 4 | Industrials | 13.73% |
| 5 | Consumer Discretionary | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Fastenal
FAST
$55.1B
| $343K | ﹤0.01% |
14,504
-9,774
| -40% | -$231K |
|
827
Emergent Biosolutions
EBS
$404M
| $334K | ﹤0.01% |
28,289
+598
| +2% | +$7.06K |
|
828
PTC
PTC
$25.6B
| $333K | ﹤0.01% |
2,770
-128
| -4% | -$15.4K |
|
829
Medifast
MED
$149M
| $328K | ﹤0.01% |
+2,843
| New | +$328K |
|
830
Simpson Manufacturing
SSD
$8.15B
| $318K | ﹤0.01% |
3,586
-167
| -4% | -$14.8K |
|
|
SI
831
DELISTED
Silvergate Capital Corporation
SI
| $316K | ﹤0.01% |
18,168
+384
| +2% | +$6.68K |
|
832
Vanguard Growth ETF
VUG
$186B
| $314K | ﹤0.01% |
+1,473
| New | +$314K |
|
833
Novanta
NOVT
$4.18B
| $314K | ﹤0.01% |
2,310
-106
| -4% | -$14.4K |
|
834
NiSource
NI
$19B
| $301K | ﹤0.01% |
10,970
-9,515
| -46% | -$261K |
|
835
CVS Health
CVS
$93.6B
| $288K | ﹤0.01% |
3,088
-1,421
| -32% | -$132K |
|
836
iShares ESG Aware MSCI EM ETF
ESGE
$5.16B
| $256K | ﹤0.01% |
+8,507
| New | +$256K |
|
837
CareDx
CDNA
$736M
| $229K | ﹤0.01% |
20,097
+425
| +2% | +$4.85K |
|
838
Dynavax Technologies
DVAX
$1.18B
| $215K | ﹤0.01% |
20,211
-129,367
| -86% | -$1.38M |
|
839
Atlanticus Holdings
ATLC
$1.03B
| $212K | ﹤0.01% |
8,089
+171
| +2% | +$4.48K |
|
|
VGR
840
DELISTED
Vector Group Ltd.
VGR
| $207K | ﹤0.01% |
17,478
+370
| +2% | +$4.39K |
|
841
Idacorp
IDA
$6.77B
| $205K | ﹤0.01% |
+1,900
| New | +$205K |
|
842
Novavax
NVAX
$1.28B
| $192K | ﹤0.01% |
18,635
+395
| +2% | +$4.06K |
|
843
Banco Bradesco
BBD
$33.6B
| $99.7K | ﹤0.01% |
34,602
| – | – |
|
844
Itaú Unibanco
ITUB
$76.6B
| $61.4K | ﹤0.01% |
14,331
-567
| -4% | -$2.43K |
|
845
Apollo Global Management
APO
$75.3B
| – | – |
-2,300,000
| Closed | -$107M |
|
846
Atea Pharmaceuticals
AVIR
$267M
| – | – |
-51,137
| Closed | -$291K |
|
847
Peabody Energy
BTU
$2.33B
| – | – |
-110,039
| Closed | -$2.73M |
|
848
Compañía de Minas Buenaventura
BVN
$5.08B
| – | – |
-440,800
| Closed | -$2.97M |
|
849
Chewy
CHWY
$17.5B
| – | – |
-20,374
| Closed | -$626K |
|
850
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| – | – |
-211,741
| Closed | -$5.16M |
|